| 000 | 01598 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518074920.0 | ||
| 264 | 0 | _c20200824 | |
| 008 | 202008s 0 0 eng d | ||
| 022 | _a2073-4409 | ||
| 024 | 7 |
_a10.3390/cells9010022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Mei-Jen | |
| 245 | 0 | 0 |
_aPeroxiredoxin 5 Silencing Sensitizes Dopaminergic Neuronal Cells to Rotenone via DNA Damage-Triggered ATM/p53/PUMA Signaling-Mediated Apoptosis. _h[electronic resource] |
| 260 |
_bCells _c12 2019 |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtaxia Telangiectasia Mutated Proteins _xmetabolism |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopaminergic Neurons _xcytology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGene Knockdown Techniques _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aParkinson Disease _xetiology |
| 650 | 0 | 4 |
_aPeroxiredoxins _xgenetics |
| 650 | 0 | 4 | _aPrimary Cell Culture |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aRotenone _xadverse effects |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xmetabolism |
| 700 | 1 | _aHuang, Hsin-Yi | |
| 700 | 1 | _aChiu, Tsung-Lang | |
| 700 | 1 | _aChang, Hui-Fen | |
| 700 | 1 | _aWu, Hsin-Rong | |
| 773 | 0 |
_tCells _gvol. 9 _gno. 1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/cells9010022 _zAvailable from publisher's website |
| 999 |
_c30444620 _d30444620 |
||